AMPH
Price
$39.14
Change
-$0.25 (-0.63%)
Updated
Dec 20 closing price
79 days until earnings call
HROW
Price
$34.22
Change
-$0.21 (-0.61%)
Updated
Dec 20, 04:59 PM (EDT)
80 days until earnings call
Ad is loading...

AMPH vs HROW

Header iconAMPH vs HROW Comparison
Open Charts AMPH vs HROWBanner chart's image
Amphastar Pharmaceuticals
Price$39.14
Change-$0.25 (-0.63%)
Volume$2.48M
CapitalizationN/A
Harrow
Price$34.22
Change-$0.21 (-0.61%)
Volume$3.87K
CapitalizationN/A
AMPH vs HROW Comparison Chart
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. HROW commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and HROW is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (AMPH: $39.14 vs. HROW: $34.22)
Brand notoriety: AMPH and HROW are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 519% vs. HROW: 101%
Market capitalization -- AMPH: $2.11B vs. HROW: $467.85M
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. HROW’s [@Pharmaceuticals: Other] market capitalization is $467.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileHROW’s FA Score has 2 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • HROW’s FA Score: 2 green, 3 red.
According to our system of comparison, HROW is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while HROW’s TA Score has 4 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 5 bearish.
  • HROW’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than HROW.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а -7.34% price change this week, while HROW (@Pharmaceuticals: Other) price change was -3.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was -10.14%.

Reported Earning Dates

AMPH is expected to report earnings on Mar 12, 2025.

HROW is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than HROW($468M). HROW has higher P/E ratio than AMPH: HROW (39.53) vs AMPH (16.69). HROW YTD gains are higher at: 205.536 vs. AMPH (-36.718). AMPH has higher annual earnings (EBITDA): 240M vs. HROW (9.95M). AMPH has more cash in the bank: 257M vs. HROW (82.8M). HROW has less debt than AMPH: HROW (191M) vs AMPH (624M). AMPH has higher revenues than HROW: AMPH (644M) vs HROW (130M).
AMPHHROWAMPH / HROW
Capitalization2.11B468M451%
EBITDA240M9.95M2,411%
Gain YTD-36.718205.536-18%
P/E Ratio16.6939.5342%
Revenue644M130M495%
Total Cash257M82.8M310%
Total Debt624M191M327%
FUNDAMENTALS RATINGS
AMPH vs HROW: Fundamental Ratings
AMPH
HROW
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
4226
SMR RATING
1..100
4097
PRICE GROWTH RATING
1..100
8138
P/E GROWTH RATING
1..100
9211
SEASONALITY SCORE
1..100
1885

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (68) in the Pharmaceuticals Other industry is in the same range as HROW (89). This means that AMPH’s stock grew similarly to HROW’s over the last 12 months.

HROW's Profit vs Risk Rating (26) in the Pharmaceuticals Other industry is in the same range as AMPH (42). This means that HROW’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's SMR Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for HROW (97). This means that AMPH’s stock grew somewhat faster than HROW’s over the last 12 months.

HROW's Price Growth Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMPH (81). This means that HROW’s stock grew somewhat faster than AMPH’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is significantly better than the same rating for AMPH (92). This means that HROW’s stock grew significantly faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHHROW
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 6 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 14 days ago
73%
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOAX12.550.22
+1.78%
Goldman Sachs Mid Cap Growth A
ETCGX43.590.66
+1.54%
Eventide Gilead C
TIAGX12.970.16
+1.25%
Timothy Plan Small/Mid Cap Growth Cl I
LBSCX31.790.29
+0.92%
Columbia Dividend Income C
BIGFX26.270.10
+0.38%
Baron International Growth Retail

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
-0.61%
AMRX - HROW
34%
Loosely correlated
+0.39%
ORGO - HROW
30%
Poorly correlated
-1.93%
AMPH - HROW
28%
Poorly correlated
-0.63%
EBS - HROW
26%
Poorly correlated
+0.50%
RMTI - HROW
26%
Poorly correlated
+1.46%
More